Ozgul, S. Et Al. 2015. Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches. NEUROCHEMISTRY INTERNATIONAL , 1-13.

Ozgul, S., Kasap, M., Akpınar, G., Kanlı, A., Guzel, N., Karaosmanoglu, K., ... Baykal, A. T.(2015). Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches. NEUROCHEMISTRY INTERNATIONAL , 1-13.

Ozgul, Sinem Et Al. "Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches," NEUROCHEMISTRY INTERNATIONAL , 1-13, 2015

Ozgul, Sinem Et Al. "Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches." NEUROCHEMISTRY INTERNATIONAL , pp.1-13, 2015

Ozgul, S. Et Al. (2015) . "Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches." NEUROCHEMISTRY INTERNATIONAL , pp.1-13.

@article{article, author={Sinem Ozgul Et Al. }, title={Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches}, journal={NEUROCHEMISTRY INTERNATIONAL}, year=2015, pages={1-13} }